In a prospective study of the natural history of coronary atherosclerosis using angiography and grayscale and radiofrequency intravascular ultrasound (IVUS)-virtual histology (VH), larger plaque burden, smaller luminal area, and plaque composition thin-cap fibroatheroma emerged as independent predictors of future adverse cardiovascular events.
T he PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study was a prospective trial of the natural history of coronary atherosclerosis using angiography and radiofrequency intravascular ultrasound (IVUS)-virtual histology (VH) to identify the clinical and lesion-related factors that predict future coronary events (1) . It was performed at 37 sites in the United States and Europe. Patients with acute coronary syndromes See page S39
were enrolled after undergoing successful percutaneous coronary intervention (PCI) of all culprit lesions responsible for the acute events. Angiography was performed of the entire coronary tree, followed by grayscale and IVUS-VH of the proximal 6 to 8 cm of all 3 epicardial arteries. All baseline angiograms and grayscale and IVUS-VH images were prospectively analyzed without knowledge of subsequent events using prespecified definitions and methodology. Plaque burden and luminal area as prospectively measured by grayscale IVUS and plaque composition as assessed by IVUS-VH were determined to be independent predictors of future adverse cardiovascular events (1) .
The main results of the PROSPECT study were as follows. The 3-year cumulative rate of major adverse cardiovascular events was 20.4%. Events were adjudicated to culprit lesions in 12.9% of patients and to nonculprit lesions in 11.6%. On multivariate analysis, nonculprit lesions associated with recurrent events were characterized by a plaque burden Ն70% (hazard ratio: 5.03; 95% confidence interval: 2.51 to 10.11; p Ͻ 0.0001), a minimal luminal area Յ 4.0 mm 2 (hazard ratio: 3.21; 95% confidence interval: 1.61 to 6.42; p ϭ 0.001), and IVUS-VH phenotype of a thin-cap fibroatheroma (TCFA) (hazard ratio: 3.35; 95% confidence interval: 1.77 to 6.36; p Ͻ 0.001).
The purpose of this report is to provide detailed information about the methodology used in PROSPECT that arrived at these findings. All reports presented in this issue of iJACC (2-9) used uniform methodology and classification as outlined in this report.
M E T H O D S
Coronary angiography. Coronary angiography before PCI, immediately after PCI, and at follow-up (at the time of the event) were performed in at least 2 orthogonal views after the administration of intracoronary nitroglycerin.
3-vessel qualitative and quantitative angiographic
analysis. All angiograms were analyzed prospectively at an independent angiographic core laboratory at the Cardiovascular Research Foundation (CRF) (New York, New York) that was blinded to the IVUS analysis and to the clinical events. Quantitative analysis was performed using proprietary methodology modified from Medis CMS software version 7.0 (Medis Medical Imaging Systems, Leiden, the Netherlands) that was first validated in 78 randomly selected coronary segments (data on file at the CRF). Qualitative analysis using standard definitions (10) included thrombus, ulceration, intimal flap, aneurysm, tortuosity, angulation, calcification, and eccentricity. Post-PCI qualitative analyses included abrupt closure, ectasia, luminal irregularities, intimal flap, thrombus, dissection, perforation, side branch loss, distal embolization, and coronary spasm. The longitudinal extension of each of these morphologies was recorded in relation to the distance from the coronary ostium. For each vessel, Thrombolysis In Myocardial Infarction (TIMI) flow, TIMI frame count, corrected TIMI frame count, and myocardial blush score were recorded before PCI, after PCI, and at follow-up.
First, all culprit and nonculprit lesions (defined as Ն30% visual diameter stenosis) were identified and their locations recorded in relation to the corresponding coronary artery ostium and nearby side branches.
Second, all culprit and nonculprit lesions before PCI, culprit lesions after PCI, and lesions causing events during follow-up were analyzed, including minimal luminal diameter, lesion length, mean reference vessel diameter (obtained by averaging 5-mm segments proximal and distal to the target lesion location), and diameter stenosis ([1 Ϫ minimal luminal diameter/reference vessel diameter] ϫ 100).
Third, all 3 epicardial vessels as well as all Ն1.5-mm-diameter side branches were divided into 29 CASS (Coronary Artery Surgery Study) segments. Each CASS segment was then subdivided into 1.5-mm-long subsegments ( Fig. 1) and analyzed. Measurements of each 1.5-mm-long subsegment included minimal luminal diameter, interpolated reference vessel diameter, and diameter stenosis. Grayscale and IVUS-VH image acquisition. Immediately after PCI, grayscale and IVUS-VH were performed within the left main coronary artery and 
proximal 6 to 8 cm of each major epicardial coronary artery using a synthetic aperture array, 20-MHz, 3.2-F catheter (Eagle Eye, Volcano Corporation, Rancho Cordova, California) after the administration of intracoronary nitroglycerin. The IVUS catheter was advanced distal to the region of interest, the guiding catheter was disengaged, and the IVUS catheter was pulled backed to the aortoostial junction using an R-100 motorized catheter pullback system (0.5 mm/s). During pullback, grayscale IVUS images were recorded, raw radiofrequency data were captured at the top of the R wave, and the reconstruction of the color-coded map by an IVUS-VH data recorder was performed (InVision Gold, Volcano Corporation). IVUS studies were archived onto CD-ROMs or DVDs. Grayscale and IVUS-VH analysis. Off-line grayscale and IVUS-VH analyses of all imaged segments were performed prospectively at an independent IVUS core laboratory at the CRF that was blinded to the angiographic analysis and to the clinical events using: 1) QCU-CMS software (Medis Medical Imaging Systems) for contouring; 2) pcVH version 2.1 software (Volcano Corporation) for contouring and data output; and 3) proprietary qVH software (developed and validated at the CRF) for qualitative segmental assessment and quantitative data output. External elastic membrane (EEM) and luminal borders were contoured for each slice (median interslice distance 0.40 mm). Quantitative IVUS measurements included EEM cross-sectional area (CSA), luminal CSA, plaque and media (EEM minus luminal) CSA, and plaque burden (plaque and media divided by EEM). IVUS-VH plaque components were color coded as dense calcium (DC) (white), necrotic core (NC) (red), fibrofatty (light green), or fibrous tissue (dark green) and reported as CSA and percents of total plaque CSA (11) (12) (13) . Volumes were calculated using Simpson's rule and reported as total volume and normalized area (volume divided by length). The slice with the minimal luminal CSA and the slice with maximal NC CSA were identified and assessed as well. The remodeling index was calculated by the EEM CSA at the minimal luminal CSA or maximal NC slice divided by the average of the proximal and distal reference EEM CSA. Qualitative grayscale IVUS morphology included plaque rupture (intraplaque cavity that communicated with the lumen with an overlying residual fibrous cap fragment) and echolucent plaque (a plaque containing a non-echo-reflective dark zone). Because the left main coronary artery was usually imaged during both left anterior descending and left circumflex coronary artery pullbacks, the run with better left main image quality was chosen. Similarly, when a proximal vessel was imaged during pullbacks from both the distal main vessel and a major side branch, the run with better proximal vessel image quality was chosen. IVUS-VH classification. IVUS-VH phenotype was classified as: 1) VH TCFA; 2) thick-cap fibroatheroma (ThCFA); 3) pathological intimal thickening (PIT); 4) fibrotic plaque; and 5) fibrocalcific plaque. Fibrotic plaque had mainly fibrous tissue, with Ͻ10% confluent NC, Ͻ10% confluent DC, and Ͻ15% fibrofatty plaque. Fibrocalcific plaque had mainly fibrous tissue, with Ͼ10% confluent DC but Ͻ10% confluent NC. PIT had a mixture of all plaque components but predominantly fibrofatty plaque, with Ͻ10% confluent NC and Ͻ10% confluent DC (Fig. 2) .
Fibroatheroma (both VH TCFA and ThCFA) was defined as Ͼ10% confluent NC (spotty red color was not considered confluent NC) (Fig. 3) . Because the resolution of IVUS-VH is 150 to 250 m, it was not possible to detect fibrous cap thickness Ͻ65 m (the typical pathologic definition of a thin fibrous cap). Therefore, if there was Ͼ30°o f NC abutting to the lumen in three consecutive slices, the fibroatheroma was classified as VH TCFA; otherwise, it was classified as ThCFA. IVUS-VH often contains a 1-pixel thickness of white separating the NC from the luminal surface that is considered to be an artifact; this was included in the qualitative assessment of NC. The total NC abutting the lumen including the isolated nonred pixels was measured in degrees (Fig. 3) .
Fibroatheromas were subclassified as having single or multiple confluent NCs (circumferential or layered) and containing or not containing DC (Fig. 2) . Because DC caused shadowing and may have affected IVUS-VH plaque classification, we reported DC in relation to the NC: DC superficial to NC, DC inside of NC, or DC outside of NC. For this purpose, grayscale IVUS was evaluated together with IVUS-VH to assess the presence and extent of shadowing from calcification.
Thus, all individual image slices were evaluated regarding: 1) existence of fibroatheroma (Ͼ10% confluent NC); 2) existence of a fibrous cap; 3) single or multiple NCs (layered or circumferential); and 4) presence of DC and its relation with NC (superficial to NC, inside of NC, or outside of NC). An overall hierarchy of fibroatheroma subtypes was pre-specified as follows (on the basis of their anticipated likelihood to be correlated with future adverse events): . In addition to vessel data and overall patient data, we constructed the grayscale and IVUS-VH data at 3 levels: lesion level, fibroatheroma level, and slice level (Fig. 4) . A lesion was defined as a segment in which Ն3 consecutive slices had Ն40% plaque burden. Lesions were considered separate if there was a Ն5-mm-long normal segment with Ͻ40% plaque burden between them. For lesion level IVUS-VH classification, the entire lesion was evaluated. A lesion could contain more than 1 fibroatheroma. The main fibroatheroma groups (VH TCFA, noncalcified ThCFA, and calcified ThCFA) required 3 consecutive slices demonstrating the same main fibroatheroma subtype. Fibroatheromas were considered multiple and distinct if they were separated by Ն3 consecutive image slices containing a different fibroatheroma subtype (VH TCFA, noncalcified ThCFA, or calcified ThCFA) or nonfibroatheroma phenotype; for example, multiple VH TCFAs were considered separate if they were separated by Ն3 consecutive non-VH TCFA-containing image slices. Then, the fibroatheroma subtype (1 to 10 as specified previously) was assigned on the basis of the maximum NC slice. Grayscale morphology (plaque rupture and echolucent plaque) was also mapped at the fibroatheroma level.
In lesions with more than 1 fibroatheroma subtype, for the lesion level VH classification, the previously described hierarchy was used; a VH TCFA took precedence over a ThCFA, and any Nonconfluent necrotic core (NC) typically appeared as spotty red color (black arrows) in the plaque. Confluent NC had a thick and continuous red color (white arrow). A typical virtual histology (VH) thin-cap fibroatheroma (TCFA) included an arc of abutting NC to the lumen of 50°(angle); this NC contained an occasional white or other nonred pixel within the abutting NC (white arrow).
Figure 4. Three Levels of Grayscale and IVUS-VH
The arrows associated with the blue line indicate consecutive intravascular ultrasound (IVUS) image slices within a vessel segment; each slice contains unique IVUS data. The 3 green lines indicate that this segment contains 3 lesions. The yellow, red, and orange lines indicate that each lesion contains more than 1 nonoverlapping fibroatheroma: virtual histology (VH) thin-cap fibroatheroma (yellow), noncalcified-cap fibroatheroma (red), or calcified-cap fibroatheroma (orange), respectively. Grayscale morphology (shown in gray or black) such as plaque rupture or echolucent plaque was also mapped to the overall segment (blue line), to individual lesions (green lines), and to the fibroatheromas (yellow, red, or orange lines) .
fibroatheroma took precedence over any nonfibroatheroma. If there was no fibroatheroma in the entire lesion, the VH classification at the minimal luminal area site was evaluated and defined as fibrotic plaque, fibrocalcific plaque, or PIT.
Coregistration with IVUS-VH and identification of lesions
responsible for nonculprit events. All angiographic and grayscale and IVUS-VH analyses were performed independently. Grayscale and IVUS-VH analyses of all imaged epicardial vessels were coregistered to the angiographic roadmap using fiduciary side branches for alignment (Fig. 5 ) with interpolation as necessary to account for different length measurements to define and match the 1.5-mmlong angiographic and grayscale and IVUS-VH slices and subsegments. Lesions responsible for events were identified using the follow-up angiogram, and then the corresponding segments and subsegments were matched side by side to the baseline angiograms and their corresponding baseline grayscale and IVUS-VH images in terms of both quantitative and qualitative morphologic analysis (Fig. 6 ).
D I S C U S S I O N

Development of definitions.
Previous angiographic natural history studies, such as CASS, demonstrated that patients with normal coronary arteries have a relatively benign prognosis. Like PROSPECT, CASS defined normal coronary arteries as having Ͻ30% diameter stenosis by visual estimation (14, 15) . Glagov et al. (16) described the concept of "compensated remodeling" and concluded that compensation by vessel enlargement failed and luminal encroachment began when plaque accumulation (i.e., plaque burden) exceeded (on average) 40% of EEM area. Many plaque regression and progression studies have reported an average overall plaque burden in the study segments of approximately 40% (17, 18) . Many IVUS substudies of interventional trials have reported an average reference segment plaque burden of 40% (19) . Again, this justifies the use of a plaque burden of 40% as the minimal threshold to define a lesion.
The minimal reported length of a pathologic TCFA is 1 to 2 mm (20 -22) . Antegrade or retrograde movement of an IVUS catheter during the systolic and diastolic cycle averages 1.5 mm (23) . In past studies, the average interslice distance in the electrocardiographically gated VH images was 0.5 mm. For these reasons, PROSPECT used a 1.5-mm (or 3 image slice) minimal length for any finding such as plaque burden Ն40%, VH TCFA, and so on. 
. Coregistration Between Angiography and IVUS
Angiographic and intravascular ultrasound (IVUS) segments were matched using side branches as fiduciary landmarks. D1 ϭ first diagonal branch; D2 ϭ second diagonal branch; LCX ϭ left circumflex coronary artery; S1 ϭ first septal perforator; S2 ϭ second septal perforator; S3 ϭ third septal perforator.
The IVUS-VH phenotype classification is based on the modified American Heart Association classification, excluding adaptive intimal thickening, intimal xanthoma, and fatty streaks, because these are typically present only in arteries with Ͻ40% plaque burden (20) . In addition, the next most common high-risk lesion morphology, plaque erosion, cannot be reliably detected by IVUS, because of its limited resolution. Therefore, for IVUS-VH classification, only the following phenotypes were considered: 1) TCFA; 2) ThCFA; 3) PIT; 4) fibrotic plaque; and 5) fibrocalcific plaque. Pathologically, the key difference between PIT and fibroatheroma is the presence of an NC. Therefore, to define fibroatheroma, we chose the presence of confluent NC Ն10% because Virmani et al. (20, 21) and Cheruvu et al. (22) reported that the amounts of overall NC for TCFA, ThCFA, and stable plaque were 23 Ϯ 17%, 15 Ϯ 20%, and 12 Ϯ 25%. IVUS-VH-related issues. The accuracy of IVUS-VH analysis behind calcium continues to be debated and probably depends on the thickness, density, and amount of calcium. However, it is unclear how often there is a definable signal compared with mostly noise behind calcium from images obtained in vivo. In cases with grayscale shadowing, VH often shows red color, which is in fact an artifact. We did not exclude data behind grayscale calcification, which may have introduced errors.
There is currently no specific VH algorithm to identify thrombus (11) (12) (13) . Thus, thrombus appears green or light green (fibrotic or fibrofatty plaque) depending on its age. In the VH analysis in PROSPECT, no attempt was made to identify thrombus and to exclude it from the overall plaque area. Therefore, thrombus could cause a TCFA to be misclassified as a ThCFA. Data acquisition issues. As previously reported, of 697 enrolled patients, grayscale and IVUS-VH images were available for 673 and 623 patients, respectively (1). Grayscale IVUS images were not available in 24 patients, because: 1) the core lab never received any IVUS image media (n ϭ 17); 2) there was too much noise in the IVUS images (n ϭ 4); 3) pullback length was inadequate (n ϭ 2); and 4) there were problems with the digital media (n ϭ 1). IVUS-VH images were not available for 50 patients, because of: 1) failure to capture IVUS-VH
Figure 6. Example of a Lesion With a Nonculprit MACE
At baseline, a 58-year-old man presented with a non-ST-segment elevation myocardial infarction, and the culprit lesion in the right coronary artery was treated. All 3 vessels were imaged, and the angiograms and intravascular ultrasound (IVUS)-virtual histology (VH) images for the left anterior descending coronary artery at baseline are shown. One year later, the patient was rehospitalized for unstable angina, with coronary angiography showing total occlusion of the mid left anterior descending coronary artery (S3 on the angiogram). The corresponding baseline IVUS-VH images for the lesion causing the nonculprit major adverse cardiac event (MACE) (mid lesion, IVUS-VH image A) showed a thin-cap fibroatheroma with a minimal luminal cross-sectional area of 3.6 mm
data (n ϭ 28, in whom only grayscale IVUS was received); 2) too much noise (n ϭ 6), segmental loss of VH (n ϭ 4), or other catheter-related problems (n ϭ 3); and 3) digital media-related problems (n ϭ 9). Eleven patients (1.6%) had complications that were attributed to 3-vessel intravascular imaging. Mostly, these complications occurred in the early stages of the trial during the learning curve.
Both the angiographic and IVUS-VH analyses were time consuming. Even when performed by experienced analysts and overread by experienced physicians, the angiographic analysis for the entire coronary tree required at least 1 day per patient, and the grayscale and IVUS-VH analysis required on average 1 day per vessel (mean 2.3 days per patient). Thus, given the software that was available at the time of this study, the total manpower required for the complete PROSPECT analysis was estimated to be 2,400 person-days. In addition, because the development of IVUS-VH algorithm and analysis software continued during the trial, several reanalyses were performed. The size of the entire image set for 697 patients was 1.5 terabytes (2.1 gigabytes/ patient). During the analysis process to protect the data, multiple image files were kept on an active server with regular backup; this required approximately 6 terabytes of storage space.
Comparison with other technologies and future directions. There are 2 other radiofrequency IVUS analytic techniques available: iMAP (Boston Scientific Corporation, Natick, Massachusetts) and integrated backscatter IVUS. Each of the 3 IVUS tissue characterization techniques uses a different algorithm, tissue color coding, and analysis scheme, and there is no uniform methodology or standard for reporting the results of IVUS-derived plaque composition, making direct comparisons difficult. In addition, there are also structural and compositional optical imaging techniques (optical coherence tomography and near infrared spectroscopy); in particular, the resolution of optical coherence tomography will allow direct measurement of vulnerable plaque fibrous cap thickness, something that was not possible in PROSPECT. There are enough differences among these diverse intravascular imaging modalities to make it difficult to use the findings of PROSPECT for any technology other than IVUS-VH (24 -28) ; each technology will probably require its own PROSPECT-like study. Furthermore, even another natural history study using IVUS-VH should be performed only after a reevaluation the image acquisition and analysis methodology and definitions used in PROSPECT.
Conversely, the systematic approach to integrating angiography, intravascular imaging, and clinical follow-up as performed in PROSPECT should be useful guidelines for any future study.
C O N C L U S I O N S
PROSPECT was a natural history study in patients with acute coronary syndromes in which 3-vessel angiography and grayscale and radiofrequency IVUS were used to prospectively characterize 3,160 IVUS lesions and to identify the patient-related and lesion-related predictors of events. Accomplishing this required the development of proprietary software to permit coregistration of angiographic and IVUS images and detailed analysis at a level not previously attempted. Future software iterations should allow these processes to be automated and streamlined, reducing their complexity and personnel burden, thereby facilitating future natural history studies and drug and device therapy trials. 
